Compare PGEN & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | PAYO |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | 47 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2013 | 2021 |
| Metric | PGEN | PAYO |
|---|---|---|
| Price | $7.70 | $7.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $8.33 | $7.69 |
| AVG Volume (30 Days) | ★ 3.7M | 2.2M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.03 | ★ 0.05 |
| Revenue | $230,981,000.00 | ★ $1,052,774,000.00 |
| Revenue This Year | $1,115.92 | $7.15 |
| Revenue Next Year | $81.04 | $10.28 |
| P/E Ratio | $258.83 | ★ $142.20 |
| Revenue Growth | N/A | ★ 7.68 |
| 52 Week Low | $2.99 | $4.08 |
| 52 Week High | $8.04 | $7.18 |
| Indicator | PGEN | PAYO |
|---|---|---|
| Relative Strength Index (RSI) | 64.70 | 51.98 |
| Support Level | $6.57 | $7.08 |
| Resistance Level | $7.72 | $7.16 |
| Average True Range (ATR) | 0.27 | 0.03 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 76.41 | 33.33 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.